Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic resonance imaging findings of the lower limb muscles in anti-mitochondrial M2 antibody-positive myositis.
Nomiya H, Hamano T, Takaku N, Sasaki H, Usui K, Sanada S, Yamaguchi T, Kitazaki Y, Endo Y, Kamisawa T, Enomoto S, Shirafuji N, Matsunaga A, Ueno A, Ikawa M, Yamamura O, Hasegawa M, Kimura H, Nishino I, Nakamoto Y. Nomiya H, et al. Among authors: hasegawa m. Neuromuscul Disord. 2023 Sep;33(9):74-80. doi: 10.1016/j.nmd.2023.07.005. Epub 2023 Jul 25. Neuromuscul Disord. 2023. PMID: 37652755
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.
Ohba S, Teranishi T, Matsumura K, Kumon M, Kojima D, Fujiwara E, Nakao K, Kuwahara K, Murayama K, Pareira ES, Yamada S, Joko M, Nakae S, Muto J, Nishiyama Y, Adachi K, Sasaki H, Abe M, Hasegawa M, Hirose Y. Ohba S, et al. Among authors: hasegawa m. Sci Rep. 2025 Jan 11;15(1):1750. doi: 10.1038/s41598-025-85339-x. Sci Rep. 2025. PMID: 39799218 Free PMC article.
Population pharmacokinetic and exposure-response analysis to support a dosing regimen of CPX-351 (NS-87) in Japanese adult and pediatric patients with untreated high-risk acute myeloid leukemia.
Imai S, Kitada A, Ogura A, Akagi M, Hasegawa M, Vasilinin G, Marier JF, Wang Q, Ichikawa T, Kusano K. Imai S, et al. Among authors: hasegawa m. Drug Metab Pharmacokinet. 2024 Nov 16;60:101038. doi: 10.1016/j.dmpk.2024.101038. Online ahead of print. Drug Metab Pharmacokinet. 2024. PMID: 39729780
4,210 results